Macrophages promote cyst growth in polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 22, Issue 10, 2011, Pages 1809-1814

  Karihaloo, Anil ^a   Koraishy, Farrukh ^a   Huen, Sarah C ^a   Lee, Yashang ^a   Merrick, David ^a   Caplan, Michael J ^a   Somlo, Stefan ^a   Cantley, Lloyd G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CXCL16 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCYSTIN 1; POLYCYSTIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOPATHOGENESIS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 80053557318     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011010084     Document Type: Article

References (24)

1. Gallagher AR, Germino GG, Somlo S: Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17, 118-130, 2010
2. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: The last 3 years. Kidney Int 76, 149-168, 2009
3. Harris PC, Torres VE: Polycystic kidney disease. Annu Rev Med 60, 321-337, 2009
4. Nadella R, Blumer JB, Jia G, Kwon M, Akbulut T, Qian F, Sedlic F, Wakatsuki T, Sweeney WE Jr, Wilson PD, Lanier SM, Park F: Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD. J Am Soc Nephrol 21, 1275-1280, 2010
5. Gardner KD Jr, Burnside JS, Elzinga LW, Locksley RM: Cytokines in fluids from polycystic kidneys. Kidney Int 39, 718-724, 1991
6. Li X, Magenheimer BS, Xia S, Johnson T, Wallace DP, Calvet JP, Li R: A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 14, 863-868, 2008
7. Zheng D, Wolfe M, Cowley BD Jr, Wallace DP, Yamaguchi T, Grantham JJ: Urinary excretion of monocyte chemoattractant protein- 1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14, 2588-2595, 2003 (Pubitemid 37169344)
8. Torres VE, Grantham JJ, Chapman AB, Kyong Tae Bae, Tao C, Guay-Woodford LM, Harris PC, Mrug M, Bennett WM, Moxey- Mims MM, Bost JE: Urinary monocyte chemotactic protein-1 (MCP1) predicts progression in autosomal dominant polycystic kidney disease (ADPKD). in J Am Soc Nephrol (2010), pp. PO1814
9. Cowley BD Jr, Ricardo SD, Nagao S, Diamond J: Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int 60, 2087-2096, 2001 (Pubitemid 33070452)
10. Mrug M, Zhou J, Woo Y, Cui X, Szalai AJ, Novak J, Churchill GA, Guay-Woodford LM: Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 73, 63-76, 2008 (Pubitemid 350273645)
11. Duffield JS: Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30, 234-254, 2010
12. Patel V, Chowdhury R, and Igarashi P: Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 18, 99-106, 2009
13. Patel V, Li L, Cobo-Stark P, Shao X, Somlo S, Lin F, Igarashi P: Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet 17, 1578-1590, 2008 (Pubitemid 351737162)
14. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22, 317-326, 2011
15. Nishio S, Tian S, Gallagher AR, Yu Z, Patel V, Igarashi P, Somlo S: Loss of oriented cell division does not initiate cyst formation. J Am Soc Nephrol 21, 295-302, 2010
16. Wei F, Karihaloo A, Yu Z, Marlier A, Seth P, Shibazaki S, Wang T, Sukhatme VP, Somlo S, Cantley LG: Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo. Kidney Int 74, 1310-1318, 2008
17. Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, Mitobe M, Louvi A, Velazquez H, Ishibe S, Cantley LG, Igarashi P, Somlo S: Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet 17, 1505-1516, 2008 (Pubitemid 351737156)
18. Wilson PD, Falkenstein D: The pathology of human renal cystic disease. Curr Top Pathol 88, 1-50, 1995
19. van Rooijen N, Sanders A, van den Berg TK: Apoptosis of macrophages induced by liposome- mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 193, 93-99, 1996 (Pubitemid 26184748)
20. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK: Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 21, 1231-1239, 2006
21. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER: Activated macrophages induce vascular proliferation. Nature 269, 804-806, 1977 (Pubitemid 8208827)
22. Lin SL, Castano AP, Nowlin BT, Lupher ML Jr, Duffield JS: Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183, 6733-6743, 2009
23. Duffield JS, Erwig LP, Wei X, Liew FY, Rees AJ, Savill JS: Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol 164, 2110-2119, 2000 (Pubitemid 30108770)
24. Cui W, Ke JZ, Zhang Q, Ke HZ, Chalouni C, Vignery A: The intracellular domain of CD44 promotes the fusion of macrophages. Blood 107, 796-805, 2006 (Pubitemid 43076408)